Issues in Psychopharmacology

April, 2014 | Vol: 12 Issue: 4

In this issue

Learning Objective

Article

The Facts on Tardive Dyskinesia

Issues in Psychopharmacology - The Carlat Psychiatry Report (TCPR)

We’re all aware that neuroleptics and other dopamine-receptor blocking agents (DRBAs) can cause a variety of movement disorders, often referred to as extrapyramidal syndromes (EPS).

Expert Q&A

Psychodynamic Psychopharmacology

David Mintz, MD, explains how psychodynamic psychopharmacology considers patients’ individuality in making treatment decisions.

Research Update

Has Research Found a Reliable Depression Biomarker in Boys?

A major obstacle in the prevention of depression is the lack of a predictive biomarker in individuals who later develop the disorder. British researchers have shown that the combination of a physiological biomarker—salivary cortisol—and the presence of depressive symptoms might be used to predict the development of major depression in adolescents.

News of Note

Stem-Cell Research Reveals Differences in Bipolar Disorder Neurons

A team of scientists from the University of Michigan Medical School studied a line of stem cells derived from patients with bipolar disorder to determine what, if any, differences could be found between these and the cells of people without the disorder.